FDA Wants More Ozempic Data; Obesity Costs How Much?!

(MedPage Today) -- In response to Novo Nordisk's request to approve a 2-mg dose of once-weekly semaglutide (Ozempic) for type 2 diabetes--it's already approved in 0.5- and 1-mg doses--the FDA hit the company with a Refusal to File letter...